Search results
Results from the WOW.Com Content Network
The National Pediatric Cancer Foundation focuses on finding less toxic and more effective treatments for pediatric cancers. This foundation works with 24 different hospitals across the US in search of treatments effective in practice. [75] Childhood Cancer International is the largest global pediatric cancer foundation.
This category includes pediatric cancers, (including benign neoplasms) in fetuses, infants, children, teens, and young adults. Note that most pediatric cancers are also rare cancers: see Category:Rare cancers.
The Children's Oncology Group (COG), a clinical trials group supported by the National Cancer Institute (NCI), is the world's largest organization devoted exclusively to pediatric cancer research. [1] The COG conducts a spectrum of clinical research and translational research trials for infants, children, adolescents, and young adults with cancer.
Childhood leukemia is leukemia that occurs in a child and is a type of childhood cancer. Childhood leukemia is the most common childhood cancer, accounting for 29% of cancers in children aged 0–14 in 2018. [ 1 ]
The International Childhood Cancer Day: a global campaign to promote awareness of childhood cancer and express support to children with cancer, and their families. It is run by SIOP in partnership with other networks, societies and organizations around the world. It is held annually on February 15. [9] The Signs and Symptoms Campaign.
The International Classification of Childhood Cancer (ICCC) is a standardized method for categorizing childhood malignancies set forth by the World Health Organization (WHO). This system bases malignancy classification on the histological traits of the tumor (type of tissue).
The Pediatric Oncology Group (POG) was a U.S. and Canadian clinical trial cooperative group created with the mission of studying childhood cancers. It was formed by the merger of the pediatric divisions of two other cooperative groups, the Southwest Oncology Group (SWOG) and the CALGB .
Jonathan Lester Finlay (born October 16, 1948) is a pediatric neuro-oncologist specializing in the management of children, adolescents and young adults with brain tumors. [1] [2] He is the director of Neuro-oncology at Nationwide Children's Hospital, where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer.